FMX103 for Rosacea
Rosacea is a chronic skin disorder that is characterized by facial redness and inflammatory lesions, afflicting an estimated 14 million people in the U.S. alone. There are several drugs currently prescribed for treating rosacea. The most commonly used topical drugs are azelaic acid, and metronidazole. Oral antibiotics, such as doxycycline and minocycline are also routinely prescribed. Rosacea lesions and inflammatory acne lesions are dermatologically similar in many ways. Based on our clinical data of FMX101 for moderate-to-severe acne, we intend to conduct initial clinical trials in the belief that FMX103 will be a safe and effective treatment for rosacea.
Phase II Clinical trial with FMX103 for rosacea is under way.